Historical and current perspectives on Clostridium botulinum diversity

Research in Microbiology

Volumn 166, Issue 4, 2015, Pages 290-302

  Smith, Theresa J ^a   Hill, Karen K ^b   Raphael, Brian H ^c  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b LOS ALAMOS NATIONAL LABORATORY   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Botulinum neurotoxins; Clostridium botulinum; Genomics; Serotype

Indexed keywords

BACTERIOCIN; BACTERIOPHAGE DNA; BOTICIN; BOTULINOLYSIN; BOTULINUM ANTISERUM; BOTULINUM TOXIN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; BOTULINUM TOXIN C; BOTULINUM TOXIN D; BOTULINUM TOXIN E; BOTULINUM TOXIN F; BOTULINUM TOXIN G; C2 TOXIN; CLOSTRIDIOLYSIN S; CRYOPROTEIN; EXOENZYME C3; METALLOPROTEINASE; PHOSPHOLIPASE; RHO FACTOR; TRANSPOSASE; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ARTICLE; BACTERIAL CHROMOSOME; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIOPHAGE; BOTULISM; CARBOXY TERMINAL SEQUENCE; CLOSTRIDIUM BOTULINUM; DNA RESPONSIVE ELEMENT; DNA SEQUENCE; GENE CLUSTER; GENE SEQUENCE; GENETIC VARIABILITY; HEAVY CHAIN; HORIZONTAL GENE TRANSFER; MASS SPECTROMETRY; MICROARRAY ANALYSIS; MICROBIAL DIVERSITY; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; REAL TIME POLYMERASE CHAIN REACTION; SEROTYPE; SINGLE NUCLEOTIDE POLYMORPHISM; TOXIN SYNTHESIS; VARIABLE NUMBER OF TANDEM REPEAT; BACTERIUM IDENTIFICATION; CLASSIFICATION; GENETICS; HISTORY; ISOLATION AND PURIFICATION; MOLECULAR TYPING; PROCEDURES; SEROTYPING;

CLOSTRIDIA; CLOSTRIDIUM BOTULINUM;

BACTERIAL TYPING TECHNIQUES; BOTULINUM TOXINS; CLOSTRIDIUM BOTULINUM; GENETIC VARIATION; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; MOLECULAR TYPING; SEROTYPING;

EID: 84928581964     PISSN: 09232508     EISSN: 17697123     Source Type: Journal    
DOI: 10.1016/j.resmic.2014.09.007     Document Type: Article

References (144)

1. Akbulut D., Grant K.A., McLauchlin J. Development and application of real-time PCR assays to detect fragments of the Clostridium botulinum types A, B, and E neurotoxin genes for investigation of human foodborne and infant botulism. Foodborne Pathog Dis 2004, 1:247-257.
2. Aktories K., Barth H. The actin-ADP-ribosylating Clostridium botulinum C2 toxin. Anaerobe 2004, 10:101-105.
3. Anniballi F., Auricchio B., Delibato E., Antonacci M., De Medici D., Fenicia L. Multiplex real-time PCR SYBR Green for detection and typing of group III Clostridium botulinum. Vet Microbiol 2012, 154:332-338.
4. Anonymous Bacillus botulinus poisoning in Detroit. JAMA 1919, 73:1373.
5. Anonymous Outbreak of food poisoning traced to ripe olives. JAMA 1919, 73:1538.
6. Anonymous Botulism from ripe olives. JAMA 1920, 74:530-531.
7. Anonymous Deaths follow the eating of ripe olives. JAMA 1920, 74:466.
8. Anza I., Skarin H., Vidal D., Lindberg A., Baverud V., Mateo R. The same clade of Clostridium botulinum strains is causing avian botulism in southern and northern Europe. Anaerobe 2014, 26:20-23.
9. Artin I., Mason D.R., Pin C., Schelin J., Peck M.W., Holst E., et al. Effects of carbon dioxide on growth of proteolytic Clostridium botulinum, its ability to produce neurotoxin, and its transcriptome. Appl Environ Microbiol 2010, 76:1168-1172.
10. Aureli P., Fenicia L., Pasolini B., Gianfranceschi M., McCroskey L.M., Hatheway C.L. Two cases of type E infant botulism caused by neurotoxigenic Clostridium butyricum in Italy. J Infect Dis 1986, 154:207-211.
11. Barash J.R., Arnon S.S. A novel strain of Clostridium botulinum that produces type B and type H botulinum toxins. J Infect Dis 2014, 209:183-191.
12. Bengtson I.A. A toxin-producing anaerobe isolated principally from fly larvae. Its relation to the organisms hitherto known to be causative factors in the production of botulism. Pub Health Rpts (US) 1923, 38:340-344.
13. Binz T., Kurazono H., Popoff M.R., Eklund M.W., Sakaguchi G., Kozaki S., et al. Nucleotide sequence of the gene encoding Clostridium botulinum neurotoxin type D. Nucleic Acids Res 1990, 18:5556.
14. Binz T., Kurazono H., Wille M., Frevert J., Wernars K., Niemann H. The complete sequence of botulinum neurotoxin type A and comparison with other clostridial neurotoxins. J Biol Chem 1990, 265:9153-9158.
15. Brussow H., Canchaya C., Hardt W.D. Phages and the evolution of bacterial pathogens: from genomic rearrangements to lysogenic conversion. Microbiol Mol Biol Rev 2004, 68:560-602. [table of contents].
16. Burke G.S. Notes on Bacillus botulinus. J Bacteriol 1919, 4:555-570. 551.
17. Campbell K., Collins M.D., East A.K. Nucleotide sequence of the gene coding for Clostridium botulinum (Clostridium argentinense) type G neurotoxin: genealogical comparison with other clostridial neurotoxins. Biochim Biophys Acta 1993, 1216:487-491.
18. Carter A.T., Paul C.J., Mason D.R., Twine S.M., Alston M.J., Logan S.M., et al. Independent evolution of neurotoxin and flagellar genetic loci in proteolytic Clostridium botulinum. BMC Genomics 2009, 10:115.
19. Carter A.T., Pearson B.M., Crossman L.C., Drou N., Heavens D., Baker D., et al. Complete genome sequence of the proteolytic Clostridium botulinum type A5 (B3') strain H04402 065. J Bacteriol 2011, 193:2351-2352.
20. Carter A.T., Stringer S.C., Webb M.D., Peck M.W. The type F6 neurotoxin gene cluster locus of group II Clostridium botulinum has evolved by successive disruption of two different ancestral precursors. Genome Biol Evol 2013, 5:1032-1037.
21. Christensen D.R., Hartman L.J., Loveless B.M., Frye M.S., Shipley M.A., Bridge D.L., et al. Detection of biological threat agents by real-time PCR: comparison of assay performance on the R.A.P.I.D., the LightCycler, and the Smart Cycler platforms. Clin Chem 2006, 52:141-145.
22. Ciccarelli A.S., Gimenez D.F. Cryoprotein produced by Clostridium botulinum type G. Infect Immun 1972, 5:985-986.
23. Ciccarelli A.S., Whaley D.N., McCroskey L.M., Gimenez D.F., Dowell V.R., Hatheway C.L. Cultural and physiological characteristics of Clostridium botulinum type G and the susceptibility of certain animals to its toxin. Appl Environ Microbiol 1977, 34:843-848.
24. Collins M.D., East A.K. Phylogeny and taxonomy of the food-borne pathogen Clostridium botulinum and its neurotoxins. J Appl Microbiol 1998, 84:5-17.
25. Dahlsten E., Korkeala H., Somervuo P., Lindstrom M. PCR assay for differentiating between group I (proteolytic) and group II (nonproteolytic) strains of Clostridium botulinum. Int J Food Microbiol 2008, 124:108-111.
26. Derman Y., Lindstrom M., Selby K., Korkeala H. Growth of group II Clostridium botulinum strains at extreme temperatures. J Food Protect 2011, 74:1797-1804.
27. Dickson E.E. Botulism. A clinical and experimental study 1918, Rockefeller Institute for Medical Research, New York.
28. Dineen S.S., Bradshaw M., Johnson E.A. Cloning, nucleotide sequence, and expression of the gene encoding the bacteriocin boticin B from Clostridium botulinum strain 213B. Appl Environ Microbiol 2000, 66:5480-5483.
29. Dover N., Barash J.R., Hill K.K., Davenport K.W., Teshima H., Xie G., et al. Clostridium botulinum strain Af84 contains three neurotoxin gene clusters: bont/A2, bont/F4 and bont/F5. PloS One 2013, 8:e61205.
30. Dover N., Barash J.R., Hill K.K., Xie G., Arnon S.S. Molecular characterization of a novel botulinum neurotoxin type H gene. J Infect Dis 2014, 209:192-202.
31. East A.K., Richardson P.T., Allaway D., Collins M.D., Roberts T.A., Thompson D.E. Sequence of the gene encoding type F neurotoxin of Clostridium botulinum. FEMS Microbiol Lett 1992, 75:225-230.
32. Eklund M.W., Poysky F.T. Activation of a toxic component of Clostridium botulinum types C and D by trypsin. Appl Microbiol 1972, 24:108-113.
33. Eklund M.W., Poysky F.T. Interconversion of type C and D strains of Clostridium botulinum by specific bacteriophages. Appl Microbiol 1974, 27:251-258.
34. Eklund M.W., Poysky F.T., Boatman E.S. Bacteriophages of Clostridium botulinum types A, B, E, and F and nontoxigenic strains resembling type E. J Virol 1969, 3:270-274.
35. Eklund M.W., Poysky F.T., Meyers J.A., Pelroy G.A. Interspecies conversion of Clostridium botulinum type C to Clostridium novyi type A by bacteriophage. Science 1974, 186:456-458.
36. Eklund M.W., Poysky F.T., Mseitif L.M., Strom M.S. Evidence for plasmid-mediated toxin and bacteriocin production in Clostridium botulinum type G. Appl Environ Microbiol 1988, 54:1405-1408.
37. Ellison J.S., Kautter J.A. Purification and some properties of two boticins. J Bacteriol 1970, 104:19-26.
38. Fach P., Micheau P., Mazuet C., Perelle S., Popoff M. Development of real-time PCR tests for detecting botulinum neurotoxins A, B, E, F producing Clostridium botulinum, Clostridium baratii and Clostridium butyricum. J Appl Microbiol 2009, 107:465-473.
39. Fahrer J., Kuban J., Heine K., Rupps G., Kaiser E., Felder E., et al. Selective and specific internalization of clostridial C3 ADP-ribosyltransferases into macrophages and monocytes. Cell Microbiol 2010, 12:233-247.
40. Fatmawati N.N., Sakaguchi Y., Suzuki T., Oda M., Shimizu K., Yamamoto Y., et al. Phospholipase C produced by Clostridium botulinum types C and D: comparison of gene, enzymatic, and biological activities with those of Clostridium perfringens alpha-toxin. Acta Med Okayama 2013, 67:9-18.
41. Fenicia L., Fach P., van Rotterdam B.J., Anniballi F., Segerman B., Auricchio B., et al. Towards an international standard for detection and typing botulinum neurotoxin-producing Clostridia types A, B, E and F in food, feed and environmental samples: a European ring trial study to evaluate a real-time PCR assay. Int J Food Microbiol 2011, 145(Suppl. 1):S152-S157.
42. Fillo S., Giordani F., Anniballi F., Gorge O., Ramisse V., Vergnaud G., et al. Clostridium botulinum group I strain genotyping by 15-locus multilocus variable-number tandem-repeat analysis. J Clin Microbiol 2011, 49:4252-4263.
43. Franciosa G., Ferreira J.L., Hatheway C.L. Detection of type A, B, and E botulism neurotoxin genes in Clostridium botulinum and other Clostridium species by PCR: evidence of unexpressed type B toxin genes in type A toxigenic organisms. J Clin Microbiol 1994, 32:1911-1917.
44. Franciosa G., Floridi F., Maugliani A., Aureli P. Differentiation of the gene clusters encoding botulinum neurotoxin type A complexes in Clostridium botulinum type A, Ab, and A(B) strains. Appl Environ Microbiol 2004, 70:7192-7199.
45. Franciosa G., Maugliani A., Scalfaro C., Aureli P. Evidence that plasmid-borne botulinum neurotoxin type B genes are widespread among Clostridium botulinum serotype B strains. PloS One 2009, 4:e4829.
46. Gimenez D.F., Ciccarelli A.S. A new type of C. botulinum. Proc Intern Symp Food Microbiol, Moscow 1966, 455-458.
47. Gimenez D.F., Ciccarelli A.S. Another type of Clostridium botulinum. Zentralbl Bakteriol Orig 1970, 215:221-224.
48. Gimenez D.F., Ciccarelli A.S. Studies on strain 84 of Clostridium botulinum. Zentralbl Bakteriol Orig 1970, 215:212-220.
49. Gimenez D.F., Ciccarelli A.S. Antigenic variations in type F botulinum toxins. Medicina 1972, 32:596-606.
50. Gimenez D.F., Gimenez J.A. Serological subtypes of botulinal neurotoxins. Botulinum and tetanus neurotoxins. Neurotransmission and biomedical aspects 1993, 421-432. Plenum Press, New York. B.R. DasGupta (Ed.).
51. Gonzalez-Escalona N., Timme R., Raphael B.H., Zink D., Sharma S.K. Whole-genome single-nucleotide-polymorphism analysis for discrimination of Clostridium botulinum group I strains. Appl Environ Microbiol 2014, 80:2125-2132.
52. Gonzalez D.J., Lee S.W., Hensler M.E., Markley A.L., Dahesh S., Mitchell D.A., et al. Clostridiolysin S, a post-translationally modified biotoxin from Clostridium botulinum. J Biol Chem 2010, 285:28220-28228.
53. Gunnison J.B., Cummings J.R., Meyer K.F. Clostridium botulinum type E. Proc Soc Exp Biol Med 1936, 35:278-280.
54. Gunnison J.B., Meyer K.F. Cultural study of an international collection of Clostridium botulinum and parabotulinum. XXXVIII. J Infect Dis 1929, 45:119-134.
55. Gunnison J.B., Meyer K.F. The occurrence of nontoxic strains of Cl. parabotulinum. XXXIV. J Infect Dis 1929, 45:79-86.
56. Hall J.D., McCroskey L.M., Pincomb B.J., Hatheway C.L. Isolation of an organism resembling Clostridium baratii which produces type F botulinal toxin from an infant with botulism. J Clin Microbiol 1985, 21:654-655.
57. Haque A., Sugimoto N., Horiguchi Y., Okabe T., Miyata T., Iwanaga S., et al. Production, purification, and characterization of botulinolysin, a thiol-activated hemolysin of Clostridium botulinum. Infect Immun 1992, 60:71-78.
58. Hatheway C.L. Bacteriology and pathology of neurotoxigenic clostridia. Botulinum and tetanus neurotoxins. Neurotransmission and biomedical aspects 1993, 491-503. Plenum Press, New York. B.R. DasGupta (Ed.).
59. Hatheway C.L., McCroskey L.M. Examination of feces and serum for diagnosis of infant botulism in 336 patients. J Clin Microbiol 1987, 25:2334-2338.
60. Hatheway C.L., McCroskey L.M., Lombard G.L., Dowell V.R. Atypical toxin variant of Clostridium botulinum type B associated with infant botulism. J Clin Microbiol 1981, 14:607-611.
61. Hauser D., Eklund M.W., Kurazono H., Binz T., Niemann H., Gill D.M., et al. Nucleotide sequence of Clostridium botulinum C1 neurotoxin. Nucleic Acids Res 1990, 18:4924.
62. Hazen E.L. A strain of B. botulinus not classified as type A, B, or C. J Infect Dis 1937, 60:260-264.
63. Hielm S., Bjorkroth J., Hyytia E., Korkeala H. Genomic analysis of Clostridium botulinum group II by pulsed-field gel electrophoresis. Appl Environ Microbiol 1998, 64:703-708.
64. Hill B.J., Skerry J.C., Smith T.J., Arnon S.S., Douek D.C. Universal and specific quantitative detection of botulinum neurotoxin genes. BMC Microbiol 2010, 10:267.
65. Hill K.K., Smith T.J. Genetic diversity within Clostridium botulinum serotypes, botulinum neurotoxin gene clusters and toxin subtypes. Curr Top Microbiol Immunol 2013, 364:1-20.
66. Hill K.K., Smith T.J., Helma C.H., Ticknor L.O., Foley B.T., Svensson R.T., et al. Genetic diversity among botulinum neurotoxin-producing clostridial strains. J Bacteriol 2007, 189:818-832.
67. Hill K.K., Xie G., Foley B.T., Smith T.J., Munk A.C., Bruce D., et al. Recombination and insertion events involving the botulinum neurotoxin complex genes in Clostridium botulinum types A, B, E and F and Clostridium butyricum type E strains. BMC Biol 2009, 7:66.
68. Hutson R.A., Collins M.D., East A.K., Thompson D.E. Nucleotide sequence of the gene coding for non-proteolytic Clostridium botulinum type B neurotoxin: comparison with other clostridial neurotoxins. Curr Microbiol 1994, 28:101-110.
69. Hutson R.A., Zhou Y., Collins M.D., Johnson E.A., Hatheway C.L., Sugiyama H. Genetic characterization of Clostridium botulinum type A containing silent type B neurotoxin gene sequences. J Biol Chem 1996, 271:10786-10792.
70. Inoue K., Iida H. Bacteriophages of Clostridium botulinum. J Virol 1968, 2:537-540.
71. Inoue K., Iida H. Phage-conversion of toxigenicity in Clostridium botulinum types C and D. Jap J Med Sci Biol 1971, 24:53-56.
72. Iyer A.V., Blinkova A.L., Yang S.Y., Harrison M., Tepp W.H., Jacobson M.J., et al. Clostridium taeniosporum is a close relative of the Clostridium botulinum Group II. Anaerobe 2008, 14:318-324.
73. Jacobson M.J., Lin G., Raphael B., Andreadis J., Johnson E.A. Analysis of neurotoxin cluster genes in Clostridium botulinum strains producing botulinum neurotoxin serotype A subtypes. Appl Environ Microbiol 2008, 74:2778-2786.
74. Jansen B.C. The toxic antigenic factors produced by Clostridium botulinum types C and D. Onderstepoort J Vet Res 1971, 38:93-98.
75. Johnson A.L., McAdams-Gallagher S.C., Sweeney R.W. Quantitative real-time PCR for detection of neurotoxin genes of Clostridium botulinum types A, B and C in equine samples. Vet J 2014, 199:157-161.
76. Kalb S.R., Baudys J., Egan C., Smith T.J., Smith L.A., Pirkle J.L., et al. Subtype and toxin variant identification of botulinum neurotoxin type A using proteomics techniques. BSL3 and BSL4 agents, proteomics, glycomics, and antigenicity 2011, Wiley-Blackwell, Hong Kong. J. Stulik, R. Toman, P. Butaye, R.G. Ulrich (Eds.).
77. Kalb S.R., Baudys J., Smith T.J., Smith L.A., Barr J.R. Three enzymatically active neurotoxins of Clostridium botulinum strain Af84: BoNT/A2,/F4, and/F5. Anal Chem 2014, 86:3254-3262.
78. Keen E.C. Paradigms of pathogenesis: targeting the mobile genetic elements of disease. Front Cell Infect Microbiol 2012, 2:161.
79. Keto-Timonen R., Heikinheimo A., Eerola E., Korkeala H. Identification of Clostridium species and DNA fingerprinting of Clostridium perfringens by amplified fragment length polymorphism analysis. J Clin Microbiol 2006, 44:4057-4065.
80. Keto-Timonen R., Nevas M., Korkeala H. Efficient DNA fingerprinting of Clostridium botulinum types A, B, E, and F by amplified fragment length polymorphism analysis. Appl Environ Microbiol 2005, 71:1148-1154.
81. Kirchner S., Kramer K.M., Schulze M., Pauly D., Jacob D., Gessler F., et al. Pentaplexed quantitative real-time PCR assay for the simultaneous detection and quantification of botulinum neurotoxin-producing clostridia in food and clinical samples. Appl Environ Microbiol 2010, 76:4387-4395.
82. Kozaki S., Kamata Y., Nishiki T., Kakinuma H., Maruyama H., Takahashi H., et al. Characterization of Clostridium botulinum type B neurotoxin associated with infant botulism in Japan. Infect Immun 1998, 66:4811-4816.
83. Kozaki S., Nakaue S., Kamata Y. Immunological characterization of the neurotoxin produced by Clostridium botulinum type A associated with infant botulism in Japan. Microbiol Immunol 1995, 39:767-774.
84. Kurochkin B., Emelyanchik K. Seal meat as a source of botulism. Vopr Pitan 1937, 1:141-148.
85. Landmann G. Ueber die ursache der Darmstadter bohnenvergiftung. Hyg Rundschau 1904, XIV:449.
86. Leuchs J. Beitraege zur kenntnis des toxins und antitoxins des Bacillus botulinus. Z Hyg Infektionskr 1910, 76:55-84.
87. Lindstrom M., Hinderink K., Somervuo P., Kiviniemi K., Nevas M., Chen Y., et al. Comparative genomic hybridization analysis of two predominant Nordic group I (proteolytic) Clostridium botulinum type B clusters. Appl Environ Microbiol 2009, 75:2643-2651.
88. Luquez C., Raphael B.H., Joseph L.A., Meno S.R., Fernandez R.A., Maslanka S.E. Genetic diversity among Clostridium botulinum strains harboring bont/A2 and bont/A3 genes. Appl Environ Microbiol 2012, 78:8712-8718.
89. Macdonald T.E., Helma C.H., Shou Y., Valdez Y.E., Ticknor L.O., Foley B.T., et al. Analysis of Clostridium botulinum serotype E strains by using multilocus sequence typing, amplified fragment length polymorphism, variable-number tandem-repeat analysis, and botulinum neurotoxin gene sequencing. Appl Environ Microbiol 2011, 77:8625-8634.
90. Macdonald T.E., Helma C.H., Ticknor L.O., Jackson P.J., Okinaka R.T., Smith L.A., et al. Differentiation of Clostridium botulinum serotype A strains by multiple-locus variable-number tandem-repeat analysis. Appl Environ Microbiol 2008, 74:875-882.
91. Marshall K.M., Bradshaw M., Pellett S., Johnson E.A. Plasmid encoded neurotoxin genes in Clostridium botulinum serotype A subtypes. BBRC 2007, 361:49-54.
92. McClung L.S., Toabe R. The egg yolk plate reaction for the presumptive diagnosis of Clostridium sporogenes and certain species of the gangrene and botulinum groups. J Bacteriol 1947, 53:139-147.
93. McCroskey L.M., Hatheway C.L., Fenicia L., Pasolini B., Aureli P. Characterization of an organism that produces type E botulinal toxin but which resembles Clostridium butyricum from the feces of an infant with type E botulism. J Clin Microbiol 1986, 23:201-202.
94. Meyer K.F., Gunnison J.B. South African cultures of Cl. botulinum and Cl. parabotulinum. XXXVII (with a description of Cl. botulinum type D N. Sp.). J Infect Dis 1929, 45:106-118.
95. Moller V., Scheibel I. Preliminary report on the isolation of an apparently new type of Cl. botulinum. Acta Path Microbiol Scand 1960, 48:80.
96. Moriishi K., Koura M., Abe N., Fujii N., Fujinaga Y., Inoue K., et al. Mosaic structures of neurotoxins produced from Clostridium botulinum types C and D organisms. Biochim Biophys Acta 1996, 1307:123-126.
97. Nevas M., Lindstrom M., Hielm S., Bjorkroth K.J., Peck M.W., Korkeala H. Diversity of proteolytic Clostridium botulinum strains, determined by a pulsed-field gel electrophoresis approach. Appl Environ Microbiol 2005, 71:1311-1317.
98. Ng V., Lin W.J. Comparison of assembled Clostridium botulinum A1 genomes revealed their evolutionary relationship. Genomics 2014, 103:94-106.
99. Olsen J.S., Scholz H., Fillo S., Ramisse V., Lista F., Tromborg A.K., et al. Analysis of the genetic distribution among members of Clostridium botulinum group I using a novel multilocus sequence typing (MLST) assay. J Microbiol Methods 2014, 96:84-91.
100. Pfenninger W. Toxico immunologic and serologic relationship of B. botulinus, type C, and B. parabotulinus. J Infect Dis 1924, 35:347-352.
101. Poulet S., Hauser D., Quanz M., Niemann H., Popoff M.R. Sequences of the botulinal neurotoxin E derived from Clostridium botulinum type E (strain Beluga) and Clostridium butyricum (strains ATCC 43181 and ATCC 43755). BBRC 1992, 183:107-113.
102. Poumeyrol M., Billon J., DeLille F., Haas C., Marmonier A., Sebald M. Intoxication botulique mortelle due a une souche de Clostridium botulinum de type AB. Med Malad Infect 1983, 13:750-754.
103. Raphael B.H., Andreadis J.D. Real-time PCR detection of the nontoxic nonhemagglutinin gene as a rapid screening method for bacterial isolates harboring the botulinum neurotoxin (A-G) gene complex. J Microbiol Methods 2007, 71:343-346.
104. Raphael B.H., Bradshaw M., Kalb S.R., Joseph L.A., Luquez C., Barr J.R., et al. Clostridium botulinum strains producing BoNT/F4 or BoNT/F5. Appl Environ Microbiol 2014, 80:3250-3257.
105. Raphael B.H., Choudoir M.J., Luquez C., Fernandez R., Maslanka S.E. Sequence diversity of genes encoding botulinum neurotoxin type F. Appl Environ Microbiol 2010, 76:4805-4812.
106. Raphael B.H., Joseph L.A., McCroskey L.M., Luquez C., Maslanka S.E. Detection and differentiation of Clostridium botulinum type A strains using a focused DNA microarray. Mole Cell Probes 2010, 24:146-153.
107. Raphael B.H., Lautenschlager M., Kalb S.R., de Jong L.I., Frace M., Luquez C., et al. Analysis of a unique Clostridium botulinum strain from the Southern hemisphere producing a novel type E botulinum neurotoxin subtype. BMC Microbiol 2012, 12:245.
108. Raphael B.H., Luquez C., McCroskey L.M., Joseph L.A., Jacobson M.J., Johnson E.A., et al. Genetic homogeneity of Clostridium botulinum type A1 strains with unique toxin gene clusters. Appl Environ Microbiol 2008, 74:4390-4397.
109. Sakaguchi Y., Hayashi T., Kurokawa K., Nakayama K., Oshima K., Fujinaga Y., et al. The genome sequence of Clostridium botulinum type C neurotoxin-converting phage and the molecular mechanisms of unstable lysogeny. PNAS (USA) 2005, 102:17472-17477.
110. Satterfield B.A., Stewart A.F., Lew C.S., Pickett D.O., Cohen M.N., Moore E.A., et al. A quadruplex real-time PCR assay for rapid detection and differentiation of the Clostridium botulinum toxin genes A, B, E and F. J Med Microbiol 2010, 59:55-64.
111. Schoenholz P., Meyer K.F. Studies on the serologic classification of B. botulinus. II. Agglutination. J Immunol 1925, X:1-53.
112. Sebaihia M., Peck M.W., Minton N.P., Thomson N.R., Holden M.T., Mitchell W.J., et al. Genome sequence of a proteolytic (Group I) Clostridium botulinum strain Hall A and comparative analysis of the clostridial genomes. Genome Res 2007, 17:1082-1092.
113. Seddon H.R. Bulbar paralysis in cattle due to the action of a toxicogenic bacillus, with a discussion on the relationship of the condition to the forage poisoning (botulism). J Comp Path Ther 1922, 35:147-190.
114. Sisco D.L. An outbreak of botulism. JAMA 1920, 74:516.
115. Skarin H., Hafstrom T., Westerberg J., Segerman B. Clostridium botulinum group III: a group with dual identity shaped by plasmids, phages and mobile elements. BMC Genomics 2011, 12:185.
116. Skarin H., Lindberg A., Blomqvist G., Aspan A., Baverud V. Molecular characterization and comparison of Clostridium botulinum type C avian strains. Avian Pathol 2010, 39:511-518.
117. Skarin H., Segerman B. Horizontal gene transfer of toxin genes in Clostridium botulinum: involvement of mobile elements and plasmids. Mob Genet Elem 2011, 213-215.
118. Smith L.D., Holdeman L.V. The pathogenic anaerobic bacteria 1968, Springfield. C.C. Thomas (Ed.).
119. Smith T.J. Clostridium botulinum genomes and genetic diversity. Molecular aspects of botulinum neurotoxin 2014, Springer. K.A. Foster (Ed.).
120. Smith T.J., Hill K.K., Foley B.T., Detter J.C., Munk A.C., Bruce D.C., et al. Analysis of the neurotoxin complex genes in Clostridium botulinum A1-A4 and B1 strains: BoNT/A3,/Ba4 and/B1 clusters are located within plasmids. PloS One 2007, 2:e1271.
121. Smith T.J., Lou J., Geren I.N., Forsyth C.M., Tsai R., Laporte S.L., et al. Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization. Infect Immun 2005, 73:5450-5457.
122. Sonnabend O., Sonnabend W., Heinzle R., Sigrist T., Dirnhofer R., Krech U. Isolation of Clostridium botulinum type G and identification of type G botulinal toxin in humans: report of five sudden unexpected deaths. J Infect Dis 1981, 143:22-27.
123. Sonnabend W.F., Sonnabend U.P., Krech T. Isolation of Clostridium botulinum type G from Swiss soil specimens by using sequential steps in an identification scheme. Appl Environ Microbiol 1987, 53:1880-1884.
124. Stringer S.C., Carter A.T., Webb M.D., Wachnicka E., Crossman L.C., Sebaihia M., et al. Genomic and physiological variability within group II (non-proteolytic) Clostridium botulinum. BMC Genomics 2013, 14:333.
125. Strom M.S., Eklund M.W., Poysky F.T. Plasmids in Clostridium botulinum and related Clostridium species. Appl Environ Microbiol 1984, 48:956-963.
126. Suen J.C., Hatheway C.L., Steigerwalt A.G., Brenner D.J. Clostridium argentinense sp. nov.: a genetically homogenous group composed of all strains of Clostridium botulinum toxin type G and some nontoxic strains previously identified as Clostridium subterminale or Clostridium hastiforme. Int J Syst Bacteriol 1988, 38:375-381.
127. Sugimoto N., Haque A., Horiguchi Y., Matsuda M. Coronary vasoconstriction is the most probable cause of death of rats intoxicated with botulinolysin, a hemolysin produced by Clostridium botulinum. Toxicon 1995, 33:1215-1230.
128. Tabita K., Sakaguchi S., Kozaki S., Sakaguchi G. Comparative studies on Clostridium botulinum type A strains associated with infant botulism in Japan and in California, USA. Jap J Med Sci Biol 1990, 43:219-231.
129. Thompson D.E., Brehm J.K., Oultram J.D., Swinfield T.J., Shone C.C., Atkinson T., et al. The complete amino acid sequence of the Clostridium botulinum type A neurotoxin, deduced by nucleotide sequence analysis of the encoding gene. Eur J Biochem 1990, 189:73-81.
130. Umeda K., Seto Y., Kohda T., Mukamoto M., Kozaki S. Genetic characterization of Clostridium botulinum associated with type B infant botulism in Japan. J Clin Microbiol 2009, 47:2720-2728.
131. Umeda K., Seto Y., Kohda T., Mukamoto M., Kozaki S. Stability of toxigenicity in proteolytic Clostridium botulinum type B upon serial passage. Microbiol Immunol 2012, 56:338-341.
132. Umeda K., Wada T., Kohda T., Kozaki S. Multi-locus variable number tandem repeat analysis for Clostridium botulinum type B isolates in Japan: comparison with other isolates and genotyping methods. Infect Genet Evol 2013, 16:298-304.
133. van Ermengem E. A new anaerobic bacillus and its relation to botulism. Rev Infect Dis 1897, 1:701-719. (originally published as "Ueber einen neuen anaeroben Bacillus und seine Beziehungen zum Botulismus" in Zeitschrift fur Hygiene und Infektionskrankheiten 26:1-56, 1897).
134. Vanhomwegen J., Berthet N., Mazuet C., Guigon G., Vallaeys T., Stamboliyska R., et al. Application of high-density DNA resequencing microarray for detection and characterization of botulinum neurotoxin-producing clostridia. PloS One 2013, 8:e67510.
135. Wagner E. Biochemical activities of B. botulinus, type C, and B. parabotulinus, "Seddon". XXIII. J Infect Dis 1924, 35:353-360.
136. Wang X., Maegawa T., Karasawa T., Kozaki S., Tsukamoto K., Gyobu Y., et al. Genetic analysis of type E botulinum toxin-producing Clostridium butyricum strains. Appl Environ Microbiol 2000, 66:4992-4997.
137. Webb R.P., Smith T.J., Wright P., Brown J., Smith L.A. Production of catalytically inactive BoNT/A1 holoprotein and comparison with BoNT/A1 subunit vaccines against toxin subtypes A1, A2, and A3. Vaccine 2009, 27:4490-4497.
138. Webb R.P., Smith T.J., Wright P.M., Montgomery V.A., Meagher M.M., Smith L.A. Protection with recombinant Clostridium botulinum C1 and D binding domain subunit (Hc) vaccines against C and D neurotoxins. Vaccine 2007, 25:4273-4282.
139. Whelan S.M., Elmore M.J., Bodsworth N.J., Atkinson T., Minton N.P. The complete amino acid sequence of the Clostridium botulinum type-E neurotoxin, derived by nucleotide-sequence analysis of the encoding gene. Eur J Biochem 1992, 204:657-667.
140. Whelan S.M., Elmore M.J., Bodsworth N.J., Brehm J.K., Atkinson T., Minton N.P. Molecular cloning of the Clostridium botulinum structural gene encoding the type B neurotoxin and determination of its entire nucleotide sequence. Appl Environ Microbiol 1992, 58:2345-2354.
141. Willems A., East A.K., Lawson P.A., Collins M.D. Sequence of the gene coding for the neurotoxin of Clostridium botulinum type A associated with infant botulism: comparison with other clostridial neurotoxins. Res Microbiol 1993, 144:547-556.
142. Winslow C.-E.A., Broadhurst J., Buchanan R.E., Krumwiede C., Rogers L.A., Smith G.H. The families and genera of the bacteria. Preliminary report of the Committee of the Society of American Bacteriologists on characterization and classification of bacterial types. J Bacteriol 1917, 2:505-566.
143. Zhang Z., Hintsa H., Chen Y., Korkeala H., Lindstrom M. Plasmid-borne type E neurotoxin gene clusters in Clostridium botulinum strains. Appl Environ Microbiol 2013, 79:3856-3859.
144. Zhou Y., Sugiyama H., Nakano H., Johnson E.A. The genes for the Clostridium botulinum type G toxin complex are on a plasmid. Infect Immun 1995, 63:2087-2091.